Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ATN International (ATNI) Asset Writedowns and Impairment (2016 - 2025)

ATN International's Asset Writedowns and Impairment history spans 16 years, with the latest figure at $2.3 million for Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment rose 33.22% year-over-year to $2.3 million; the TTM value through Dec 2025 reached $8.8 million, up 48.15%, while the annual FY2025 figure was $8.8 million, 48.15% up from the prior year.
  • Asset Writedowns and Impairment reached $2.3 million in Q4 2025 per ATNI's latest filing, down from $2.4 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $2.4 million in Q3 2025 to a low of $998000.0 in Q4 2023.
  • Average Asset Writedowns and Impairment over 5 years is $1.6 million, with a median of $1.5 million recorded in 2021.
  • The largest YoY upside for Asset Writedowns and Impairment was 177.24% in 2021 against a maximum downside of 44.92% in 2021.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $1.5 million in 2021, then increased by 11.44% to $1.7 million in 2022, then plummeted by 42.11% to $998000.0 in 2023, then surged by 74.05% to $1.7 million in 2024, then soared by 33.22% to $2.3 million in 2025.
  • Per Business Quant, the three most recent readings for ATNI's Asset Writedowns and Impairment are $2.3 million (Q4 2025), $2.4 million (Q3 2025), and $2.3 million (Q2 2025).